R2R1/2 IN DIAGNOSIS AND THERAPY
The present invention stems from the finding that two genes designated R2R1and R2R2, play important roles in tissue development and cancer biology. In particular, the inventors have discovered that these two genes are expressed in pulmonary cells and are required for late branching morphogenesis of...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | PEETERS, PIETER, JOHAN AERSSENS, JEROEN, MARCEL, MARIA, ROGER DE HOOGT, RONALD, ANTHONIUS DE RUITER, MARCUS, CORNELIS VAN BREMPT, RONALD, KAREL, LOUISA |
description | The present invention stems from the finding that two genes designated R2R1and R2R2, play important roles in tissue development and cancer biology. In particular, the inventors have discovered that these two genes are expressed in pulmonary cells and are required for late branching morphogenesis of pulmonary epithelium and endothelium and support the development/maintenance of the refined three dimensional architecture of the lung. These genes are essential in the squamous differentiation program and development/ maintenance of the progenitor (Krtl4 expressing) cell pool. Moreover, the inventors have identified crucial roles for these genes in cancer biology, particularly processes associated with the acquisition of an immortal and metastatic phenotype (including cancer progression and metastasis) and pulmonary and cardiac development. Accordingly, the invention provides compounds and methods for use in the treatment of cardiac and pulmonary diseases and well as in cancer. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP2670769A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP2670769A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP2670769A13</originalsourceid><addsrcrecordid>eNrjZJAPMgoy1DdS8PRTcPF0dPfzD_YMVnD0c1EI8XANcgyI5GFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BRmbmBuZmlo6GxkQoAQBbUCDI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>R2R1/2 IN DIAGNOSIS AND THERAPY</title><source>esp@cenet</source><creator>PEETERS, PIETER, JOHAN ; AERSSENS, JEROEN, MARCEL, MARIA, ROGER ; DE HOOGT, RONALD, ANTHONIUS ; DE RUITER, MARCUS, CORNELIS ; VAN BREMPT, RONALD, KAREL, LOUISA</creator><creatorcontrib>PEETERS, PIETER, JOHAN ; AERSSENS, JEROEN, MARCEL, MARIA, ROGER ; DE HOOGT, RONALD, ANTHONIUS ; DE RUITER, MARCUS, CORNELIS ; VAN BREMPT, RONALD, KAREL, LOUISA</creatorcontrib><description>The present invention stems from the finding that two genes designated R2R1and R2R2, play important roles in tissue development and cancer biology. In particular, the inventors have discovered that these two genes are expressed in pulmonary cells and are required for late branching morphogenesis of pulmonary epithelium and endothelium and support the development/maintenance of the refined three dimensional architecture of the lung. These genes are essential in the squamous differentiation program and development/ maintenance of the progenitor (Krtl4 expressing) cell pool. Moreover, the inventors have identified crucial roles for these genes in cancer biology, particularly processes associated with the acquisition of an immortal and metastatic phenotype (including cancer progression and metastasis) and pulmonary and cardiac development. Accordingly, the invention provides compounds and methods for use in the treatment of cardiac and pulmonary diseases and well as in cancer.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2013</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20131211&DB=EPODOC&CC=EP&NR=2670769A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20131211&DB=EPODOC&CC=EP&NR=2670769A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PEETERS, PIETER, JOHAN</creatorcontrib><creatorcontrib>AERSSENS, JEROEN, MARCEL, MARIA, ROGER</creatorcontrib><creatorcontrib>DE HOOGT, RONALD, ANTHONIUS</creatorcontrib><creatorcontrib>DE RUITER, MARCUS, CORNELIS</creatorcontrib><creatorcontrib>VAN BREMPT, RONALD, KAREL, LOUISA</creatorcontrib><title>R2R1/2 IN DIAGNOSIS AND THERAPY</title><description>The present invention stems from the finding that two genes designated R2R1and R2R2, play important roles in tissue development and cancer biology. In particular, the inventors have discovered that these two genes are expressed in pulmonary cells and are required for late branching morphogenesis of pulmonary epithelium and endothelium and support the development/maintenance of the refined three dimensional architecture of the lung. These genes are essential in the squamous differentiation program and development/ maintenance of the progenitor (Krtl4 expressing) cell pool. Moreover, the inventors have identified crucial roles for these genes in cancer biology, particularly processes associated with the acquisition of an immortal and metastatic phenotype (including cancer progression and metastasis) and pulmonary and cardiac development. Accordingly, the invention provides compounds and methods for use in the treatment of cardiac and pulmonary diseases and well as in cancer.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2013</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAPMgoy1DdS8PRTcPF0dPfzD_YMVnD0c1EI8XANcgyI5GFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BRmbmBuZmlo6GxkQoAQBbUCDI</recordid><startdate>20131211</startdate><enddate>20131211</enddate><creator>PEETERS, PIETER, JOHAN</creator><creator>AERSSENS, JEROEN, MARCEL, MARIA, ROGER</creator><creator>DE HOOGT, RONALD, ANTHONIUS</creator><creator>DE RUITER, MARCUS, CORNELIS</creator><creator>VAN BREMPT, RONALD, KAREL, LOUISA</creator><scope>EVB</scope></search><sort><creationdate>20131211</creationdate><title>R2R1/2 IN DIAGNOSIS AND THERAPY</title><author>PEETERS, PIETER, JOHAN ; AERSSENS, JEROEN, MARCEL, MARIA, ROGER ; DE HOOGT, RONALD, ANTHONIUS ; DE RUITER, MARCUS, CORNELIS ; VAN BREMPT, RONALD, KAREL, LOUISA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP2670769A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2013</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>PEETERS, PIETER, JOHAN</creatorcontrib><creatorcontrib>AERSSENS, JEROEN, MARCEL, MARIA, ROGER</creatorcontrib><creatorcontrib>DE HOOGT, RONALD, ANTHONIUS</creatorcontrib><creatorcontrib>DE RUITER, MARCUS, CORNELIS</creatorcontrib><creatorcontrib>VAN BREMPT, RONALD, KAREL, LOUISA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PEETERS, PIETER, JOHAN</au><au>AERSSENS, JEROEN, MARCEL, MARIA, ROGER</au><au>DE HOOGT, RONALD, ANTHONIUS</au><au>DE RUITER, MARCUS, CORNELIS</au><au>VAN BREMPT, RONALD, KAREL, LOUISA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>R2R1/2 IN DIAGNOSIS AND THERAPY</title><date>2013-12-11</date><risdate>2013</risdate><abstract>The present invention stems from the finding that two genes designated R2R1and R2R2, play important roles in tissue development and cancer biology. In particular, the inventors have discovered that these two genes are expressed in pulmonary cells and are required for late branching morphogenesis of pulmonary epithelium and endothelium and support the development/maintenance of the refined three dimensional architecture of the lung. These genes are essential in the squamous differentiation program and development/ maintenance of the progenitor (Krtl4 expressing) cell pool. Moreover, the inventors have identified crucial roles for these genes in cancer biology, particularly processes associated with the acquisition of an immortal and metastatic phenotype (including cancer progression and metastasis) and pulmonary and cardiac development. Accordingly, the invention provides compounds and methods for use in the treatment of cardiac and pulmonary diseases and well as in cancer.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre ; ger |
recordid | cdi_epo_espacenet_EP2670769A1 |
source | esp@cenet |
subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
title | R2R1/2 IN DIAGNOSIS AND THERAPY |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T04%3A15%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PEETERS,%20PIETER,%20JOHAN&rft.date=2013-12-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP2670769A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |